CD19-CD22 targeted T cells

· Hrain Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19-CD22 targeted T cells, covering 2025-01-07 to 2025-01-07. Get the full timeline:

Most recent: Clinical Trial Update: Human CD19-CD22 Targeted T Cells Injection for Refractory/Relapsed Central Nervous System Leukemia/Lymphoma Patients [EARLY_Phase 1]

See pricing